Sumitomo Chemical Co., Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 140,000 shares at $7.98 ($1.1M) on 2020-03-27, disclosed to the SEC on 2020-03-30.
Open-market purchase of $1.1M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.94 | 70,000 | $556K | 49.9% |
| 2 | $7.98 | 70,000 | $559K | 50.1% |
| Total | $7.96 avg | 140,000 | $1.1M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-22 | $2.7M | — | Filing → |
| MYOV | BUY | 2021-09-20 | $2.8M | — | Filing → |
| MYOV | BUY | 2021-09-14 | $4.6M | — | Filing → |